- Peripheral T-Cell Lymphoma of Urinary Bladder Presenting With Just Irritative Voiding Symptoms
-
Kim BH
- KMID: 2530299
- Korean J Urol Oncol.
- 2022 May;20(2):133-137.
- doi: 10.22465/kjuo.2022.20.2.133
Peripheral T-cell lymphoma (PTCL) of the urinary bladder is rare. PTCL can either be primary or secondary and is difficult to differentiate from other inflammatory bladder lesions. We report a... -
- CITED
-
- Close
- SHARE
-
- Close
- The Present and Future of Intravesical Therapy in Bladder Cancer
-
Seong SW, Shin Y, Chang IH, Kim JH
- KMID: 2530294
- Korean J Urol Oncol.
- 2022 May;20(2):82-91.
- doi: 10.22465/kjuo.2022.20.2.82
Intravesical therapy is the gold standard in the treatment of nonmuscle invasive bladder cancer (NMIBC). Despite the efficacy of intravesical therapies, the best treatment options are not determined yet. Development... -
- CITED
-
- Close
- SHARE
-
- Close
- Prostate-Specific Antigen Variation as a Predictor of Prostate Cancer in Patients With Prostate-Specific Antigen ≤20 ng/mL Who Underwent Magnetic Resonance Imaging-Targeted Prostate Biopsy
-
Hwang TH, Lee KS, Koo KC, Chung BH, Yoo JW
- KMID: 2530298
- Korean J Urol Oncol.
- 2022 May;20(2):123-132.
- doi: 10.22465/kjuo.2022.20.2.123
Purpose: We investigated the role of prostate-specific antigen (PSA) variation as a predictor of prostate cancer in patients who underwent prebiopsy multiparametric magnetic resonance imaging (MRI). Materials and Methods: The clinicopathological... -
- CITED
-
- Close
- SHARE
-
- Close
- Enhanced Recovery After Surgery Program for Radical Cystectomy
-
Kwon WA, Seo HK
- KMID: 2530295
- Korean J Urol Oncol.
- 2022 May;20(2):92-106.
- doi: 10.22465/kjuo.2022.20.2.92
Even with advances in perioperative medical care, anesthetic management, and surgical techniques, radical cystectomy (RC) which remains the gold standard therapy for the treatment of muscle-invasive bladder cancer, yet is... -
- CITED
-
- Close
- SHARE
-
- Close
- Update of the Diagnostic and Therapeutic Role of the Pelvic Lymph Node Dissection Boundaries During Radical Cystectomy in Muscle Invasive Bladder Cancer
-
Kwon WA, Seo HK
- KMID: 2530293
- Korean J Urol Oncol.
- 2022 May;20(2):71-81.
- doi: 10.22465/kjuo.2022.20.2.71
Radical cystectomy (RC) is the gold standard treatment option for muscle invasive bladder cancer (MIBC). However, up to 25% of patients who undergo RC show metastatic lymph node deposits during... -
- CITED
-
- Close
- SHARE
-
- Close
- Trends of First-Line Targeted Therapy in Korean Patients With Metastatic Clear Cell Renal Cell Carcinoma: Sunitinib Versus Pazopanib, a Multicenter Study
-
Choi M, Shin TJ, Kim BH, Kim CI, Lee KS, Choi SH, Kim HT, Kim TH, Kwon TG, Ko YH, Hah YS, Park JS, Kwon SY
- KMID: 2530297
- Korean J Urol Oncol.
- 2022 May;20(2):115-122.
- doi: 10.22465/kjuo.2022.20.2.115
Purpose: There have been few reports on comparison between sunitinib and pazopanib as first-line targeted therapy in Korean metastatic clear cell renal cell carcinoma (ccRCC). We sought to analyze the... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Utility of Combining Prostate Health Index and PI-RADS Version 2 to Improve Detection of Clinically Significant Prostate Cancer
-
Song W, Lee CU, Chung JH, Kang M, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Lee HM
- KMID: 2530296
- Korean J Urol Oncol.
- 2022 May;20(2):107-114.
- doi: 10.22465/kjuo.2022.20.2.107
Purpose: To evaluate the performance of combining prostate health index (PHI) and Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) for detection of clinically significant prostate cancer (csPCa). Materials and... -
- CITED
-
- Close
- SHARE
-
- Close
